NYSE - Delayed Quote USD

Avantor, Inc. (AVTR)

13.41
+0.57
+(4.44%)
At close: May 16 at 4:00:02 PM EDT
13.33
-0.08
(-0.60%)
After hours: May 16 at 7:37:58 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Michael Stubblefield President, CEO & Director 3.25M -- 1973
Mr. R. Brent Jones Executive VP & CFO 1.2M -- 1970
Mr. Claudius O. Sokenu Executive VP, Corporate Secretary and Chief Legal & Compliance Officer 1.01M -- 1968
Mr. James Bramwell Executive VP of Sales & Customer Excellence 959.49k -- 1967
Mr. Benoit Gourdier Executive Vice President of Bioscience Production 1.05M -- 1967
Mr. Steven W. Eck Senior VP, Corporate Controller & Chief Accounting Officer -- -- 1977
Mr. Michael Wondrasch Executive VP & Chief Information Officer 808.63k -- 1969
Ms. Allison K. Hosak Senior VP of Global Communications & Brand -- -- --
Ms. Kitty Sahin Executive VP of Strategy & Corporate Development -- -- 1970
Ms. Brittany Hankamer Executive VP & Chief Human Resources Officer -- -- 1971

Avantor, Inc.

Radnor Corporate Center
Building One Suite 200 100 Matsonford Road
Radnor, PA 19087
United States
610 386 1700 https://www.avantorsciences.com
Sector: 
Healthcare
Full Time Employees: 
13,500

Description

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Corporate Governance

Avantor, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 1. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 1; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 24, 2025 at 12:30 PM UTC - July 28, 2025 at 12:30 PM UTC

Avantor, Inc. Earnings Date

Recent Events

May 12, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 28, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 25, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

March 28, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

February 7, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

January 8, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 25, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 7, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

July 26, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers